- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Results
7
0 new
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
7 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CLDX | US$24.61 | 7.3% | -36.3% | US$1.6b | US$67.10 | PS163.7x | E26.1% | n/a | ||
2005 | HK$3.15 | -1.9% | -31.1% | HK$9.5b | HK$5.74 | PE6.8x | E6.6% | 5.7% | ||
775 | HK$0.45 | 9.8% | -21.1% | HK$4.4b | n/a | PS0.8x | n/a | 0% | ||
BVXP | UK£32.00 | 0% | -24.7% | UK£167.0m | UK£51.00 | PE20.6x | n/a | 4.8% | ||
MRVI | US$5.23 | 15.2% | -17.0% | US$1.2b | US$9.07 | PS2.7x | E83.9% | n/a | ||
TRJ | AU$0.93 | -2.1% | -18.4% | AU$144.7m | AU$1.45 | PS0.9x | E98.8% | n/a | ||
SNDL | US$1.76 | -2.2% | 21.4% | US$472.6m | US$3.19 | PS0.7x | E144.4% | n/a |
Page 1 of 1